Colace and Omnaris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Colace (docusate ) and Omnaris (ciclesonide). Common drug interactions include decreased appetite among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Colace and Omnaris. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Colace?

Colace has active ingredients of docusate . It is often used in constipation. eHealthMe is studying from 41,841 Colace users. Check the latest studies of Colace.

What is Omnaris?

Omnaris has active ingredients of ciclesonide. It is often used in allergies. eHealthMe is studying from 3,970 Omnaris users. Check the latest studies of Omnaris.



On Jul, 28, 2026

28 people who take Colace and Omnaris together, and have interactions are studied.

Colace and Omnaris drug interactions.

What are the common drug interactions of Colace and Omnaris, by gender? *:

female:

  1. Decreased appetite
  2. Device failure
  3. Dizziness
  4. Epistaxis (bleed from the nose)
  5. Eye pruritus (eye itching)
  6. Facial bones fracture (bone fracture of face)
  7. Fatigue (feeling of tiredness)
  8. Frequent bowel movements
  9. Gait disturbance
  10. Haemarthrosis (haemarthrosis is where blood is able to enter the joint capsule)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Cough
  3. Papule
  4. Paratracheal lymphadenopathy (disease affecting the lymph nodes of para tracheal)
  5. Productive cough
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)
  8. Tooth infection
  9. Upper-airway cough syndrome
  10. Diffuse large b-cell lymphoma (cancer of b cells, a type of white blood cell)

What are the common drug interactions of Colace and Omnaris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anion gap increased
  2. Aphasia (damage to the parts of the brain that control language)
  3. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)
  4. Blood bicarbonate decreased
  5. Blood calcium decreased
  6. Blood immunoglobulin g increased
  7. Blood phosphorus increased
  8. Blood sodium decreased
  9. Blood thyroid stimulating hormone increased
  10. Blood urine present

50-59:

  1. Death
  2. Back pain
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  4. Blood pressure increased
  5. Dyspepsia (indigestion)
  6. Fall
  7. Herpes zoster
  8. Intervertebral disc protrusion (spinal disc protrusion)
  9. Limb discomfort (discomfort in leg)
  10. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)

60+:

  1. Weight decreased
  2. Cough
  3. Papule
  4. Paratracheal lymphadenopathy (disease affecting the lymph nodes of para tracheal)
  5. Productive cough
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)
  8. Tooth infection
  9. Upper-airway cough syndrome
  10. Asthenia (weakness)

What are the existing conditions these people have? *

  1. Idiopathic Pulmonary Fibrosis (chronic lung disease): 11 people, 39.29%
  2. Burkitt Lymphoma (cancer of the lymphatic system): 8 people, 28.57%
  3. High Blood Pressure: 6 people, 21.43%
  4. Pain: 5 people, 17.86%
  5. Asthma: 5 people, 17.86%
  6. Allergic Rhinitis: 3 people, 10.71%
  7. Drowsiness: 3 people, 10.71%
  8. Insomnia (sleeplessness): 3 people, 10.71%
  9. Hypersensitivity: 3 people, 10.71%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Colace and Omnaris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Colace and Omnaris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Colace:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Omnaris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Colace and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Omnaris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on docusate and ciclesonide (the active ingredients of Colace and Omnaris, respectively), and Colace and Omnaris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: